Not applicableWithdrawnNCT00329017What this trial is testingProtocol for Postmenopausal Women at Increased Risk of Developing Breast CancerWho this might be right forBreast Cancer Carol Fabian, MD
Testing effectiveness (Phase 2)Study completedNCT00291694What this trial is testingProtocol for Women at Increased Risk of Developing Breast CancerWho this might be right forBreast Cancer Carol Fabian, MD 72
Large-scale testing (Phase 3)Active Not RecruitingNCT01905046What this trial is testingMetformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast CancerWho this might be right forAtypical Ductal Breast HyperplasiaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+2 more Alliance for Clinical Trials in Oncology 86
Not applicableUnknownNCT01034891What this trial is testingWomen At Risk: The High Risk Breast Cancer ProgramWho this might be right forBreast Cancer New York Presbyterian Hospital 2,000
Large-scale testing (Phase 3)Active Not RecruitingNCT01357772What this trial is testingTrial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-upWho this might be right forCarcinoma, Intraductal, NoninfiltratingRecurrence, Local NeoplasmBreast Neoplasms+1 more Andrea DeCensi 500
Not applicableStudy completedNCT00620087What this trial is testingMolecular Breast Imaging in Women With Atypia and LCISWho this might be right forAtypical Lobular HyperplasiaAtypical Ductal HyperplasiaLobular Carcinoma in Situ Mayo Clinic 66
Not applicableStudy completedNCT00291083What this trial is testingProtocol for Postmenopausal Women at Increased Risk of Developing Breast CancerWho this might be right forBreast Cancer Carol Fabian, MD 229
Not applicableStudy completedNCT01166763What this trial is testingModulation of Breast Cancer Risk Biomarkers by High Dose Vitamin DWho this might be right forBreast Cancer Carol Fabian, MD 30
Not applicableStudy completedNCT01975363What this trial is testingPilot Study of Curcumin for Women With Obesity and High Risk for Breast CancerWho this might be right forAtypical Ductal Breast HyperplasiaBRCA1 Gene MutationBRCA2 Gene Mutation+2 more Ohio State University Comprehensive Cancer Center 29
Not applicableLooking for participantsNCT00291096What this trial is testingHigh Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast CancerWho this might be right forBreast Cancer Carol Fabian, MD 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT05941520What this trial is testingAcolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast CancerWho this might be right forBreast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT00637481What this trial is testingA Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast CancerWho this might be right forAtypical Ductal Breast HyperplasiaBreast CancerDuctal Breast Carcinoma in Situ+1 more National Cancer Institute (NCI) 66
Not applicableLooking for participantsNCT05178498What this trial is testingImpact of Dietary Inflammatory Potential on Breast Cancer RiskWho this might be right forBreast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+2 more Ohio State University Comprehensive Cancer Center 960
Not applicableStudy completedNCT01052740What this trial is testingX-Ray Mammography Standard of Care ProtocolWho this might be right forBreast CancerInvasive CarcinomaIn Situ Carcinoma+2 more National Institutes of Health Clinical Center (CC) 108
Not applicableUnknownNCT05932758What this trial is testingExcisional Vacuum-Assisted Breast BiopsyWho this might be right forAtypical Ductal HyperplasiaDuctal Carcinoma in Situ European Institute of Oncology 300
Testing effectiveness (Phase 2)Study completedNCT00291135What this trial is testingProtocol for Women at Increased Risk of Developing Breast CancerWho this might be right forBreast Cancer Carol Fabian, MD 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT02928978What this trial is testingRuxolitinib for Premalignant Breast DiseaseWho this might be right forDuctal Carcinoma In SituAtypical Lobular HyperplasiaAtypical Ductal Hyperplasia+1 more Julie Nangia 100
Not applicableNot Yet RecruitingNCT03868475What this trial is testingComparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast LesionsWho this might be right forBreast FibroadenomaAtypical Ductal HyperplasiaAtypical Lobular Hyperplasia+7 more London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 90
Not applicableLooking for participantsNCT05755269What this trial is testingAdding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic WomenWho this might be right forBreast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+1 more Mayo Clinic 50
Not applicableEnded earlyNCT03505372What this trial is testingRole of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal HyperplasiaWho this might be right forAtypical Ductal Hyperplasia Dana-Farber Cancer Institute 5